In the BioHarmony Drug Report Database
Brexucabtagene autoleucel
Tecartus (brexucabtagene autoleucel) is a gene pharmaceutical. It is marketed in the US.
Trade Name
|
Tecartus |
|---|---|
Common Name
|
brexucabtagene autoleucel |
ChEMBL ID
|
CHEMBL4594618 |
Indication
|
mantle-cell lymphoma |
Drug Class
|
Image (chem structure or protein)
